Skip to content

INVESTORS & MEDIA

Events & Presentations

Events
Date Event Details Remind Me
Jan 7–11, 2018
36th Annual J.P. Morgan Healthcare Conference

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will present a corporate overview. The conference will be held at the Westin St. Francis in San Francisco, CA.


36th Annual J.P. Morgan Healthcare Conference

Remind Me

Please sign up for Email alerts.


Dec 6, 2017
2017 Citi Global Healthcare Conference

John McGrath, Jr., the Company’s Executive Vice President and Chief Financial Officer, will participate in one-on-one meetings with investors on Wednesday, December 6, 2017. The Conference will be held at The Lotte New York Palace in New York, NY.


2017 Citi Global Healthcare Conference

Remind Me

Please sign up for Email alerts.


Dec 5, 2017
Global Mizuho Investor Conference NY

John McGrath, Jr., the Company’s Executive Vice President and Chief Financial Officer, will participate in one-on-one meetings with investors on Tuesday, December 5, 2017. The Conference will be held at The Lotte New York Palace in New York, NY.


Global Mizuho Investor Conference NY

Remind Me

Please sign up for Email alerts.


Nov 29, 2017
4:35 PM ET
Evercore ISI BioPharma Catalyst/Deep Dive Conference

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will participate in a fireside chat discussion on Wednesday, November 29, 2017 at 4:35 p.m. EDT. The conference will be held at the Boston Harbor Hotel in Boston, MA.


Evercore ISI BioPharma Catalyst/Deep Dive Conference

Remind Me

Please sign up for Email alerts.


Nov 15, 2017
10:00 AM UK
Jefferies 2017 London Healthcare Conference

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will present a corporate overview. The conference will be held at the Waldorf Hilton in London, UK.


Oct 25–28, 2017
MSParis2017 Congress, the 7th Joint Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Atara’s collaborating investigators will present results from two studies during the upcoming MSParis 2017 Congress. Updated, interim results will be presented from a Phase 1 study of an autologous version of ATA188, an Epstein-Barr Virus (EBV) specific T-cell immunotherapy, conducted by the Company’s collaborating investigators at the QIMR Berghofer Medical Research Institute and The University of Queensland.  The meeting will also feature new results by Atara and its collaborating investigators at Stanford Medicine characterizing the molecular signature of EBV in MS brain lesions. The MSParis2017 Congress will be held October 25-28, 2017, at the Palais des Congrès de Paris, in Paris, France. Details for the poster presentations are as follows:

Abstract Title: Safety and clinical improvement in a phase 1 trial of autologous Epstein-Barr virus-specific T cell therapy in patients with progressive multiple sclerosis

Session Title: Poster Session 1
Presentation Date & Time: Thursday, October 26, 2017; 15:30 CEST
Lead Authors: Michael Pender, M.D., and Professor Rajiv Khanna

Abstract Title: Molecular signature of Epstein-Barr virus infection in multiple sclerosis brain lesions

Session Title: Poster Session 2
Presentation Date & Time: Friday, October 27, 2017; 15:30 CEST
Lead Authors: May Han, M.D., and Lawrence Steinman, M.D.

View Press Release


Oct 18, 2017
3:00 PM PT
BIO Investor Forum

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will participate in a panel discussion titled “Lessons from the Immuno-Oncology Inhibitor Landscape for Neurology and Beyond” on Wednesday, Monday, October 18, 2017 at 3:00 PM Pacific time.  The conference will be held at the Westin St. Francis in San Francisco, CA.

Full Conference Agenda


Sep 26, 2017
11:30 AM ET
Cantor Fitzgerald Healthcare Conference

John Craighead, Ph.D., the Company’s Vice President of Investor Relations and Corporate Communications, will present a corporate overview on Tuesday, September 26, 2017 at 11:30 a.m. EDT. The Conference will be held at the InterContinental New York Barclay Hotel in New York, NY.


Sep 25, 2017
Cell & Gene Therapy CEO

Derrell Porter, M.D. the Company's Senior Vice President and Global Commercial Head, will participate in a panel discussion titled “Business Model Efficiencies: Identifying and Overcoming Hurdles” on Monday, September 25, 2017 at 9:45 AM Eastern time.  Dr. Porter will also moderate a panel focused on “Commercial Optimization: Overcoming Challenges to Market Access” at 3:30 PM Eastern time on Monday.  The conference will be held at the Four Seasons in Boston, MA.

Full Conference Agenda


Sep 19, 2017
Mizuho Biotechnology CNS Deep Management Day

AJ Joshi, M.D. the Company’s Senior Vice President, Global Medical Affairs and MS Franchise Lead, will participate in one-on-one meetings with investors on Tuesday, September 19, 2017.  The conference will be held at The Langham Hotel in Boston, MA.


Sep 11, 2017
4:15 PM ET
Morgan Stanley Global Healthcare Conference

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will participate in a fireside chat discussion on Monday, September 11, 2017 at 4:15 p.m. EDT. The conference will be held at the Grand Hyatt Hotel in New York, NY


Sep 7, 2017
Citi 12th Annual Biotech Conference

Chris Haqq, M.D., Ph.D., the Company’s Executive Vice President of Research and Development and Chief Scientific Officer, will attend Citi’s 12th Annual Biotech Conference on Thursday, September 7th, 2017.  The conference will be held at the Mandarin Oriental Hotel in Boston, MA.


Sep 6, 2017
CAR-TCR Summit 2017

Chris Haqq, M.D., Ph.D., the Company's Executive Vice President of Research and Development and Chief Scientific Officer, will participate in a panel discussion titled “How Can We Improve Patient Selection and Recruitment for CAR-TCR Therapies” on Wednesday, September 6, 2017 at 6:10 PM Eastern time.  The conference will be held at the Seaport Hotel & World Trade Center in Boston, MA.


Aug 9, 2017
12:30 PM ET
Canaccord Genuity 37th Annual Growth Conference

Isaac Ciechanover, M.D., the Company's President and Chief Executive Officer, will present a corporate overview on Wednesday, August 9, 2017 at 12:30 PM Eastern time. The conference will be held at the InterContinental Boston in Boston, MA.


Jun 21, 2017
11:00 AM ET
JMP Securities 2017 Life Sciences Conference

John Craighead, Ph.D., the Company's Vice President of Investor Relations and Corporate Communications, participated in a panel discussion titled "Immuno-oncology: From the Lab to the Clinic" on Wednesday, June 21, 2017 at 11:00 a.m. ET.


Jun 13, 2017
4:00 PM PT
Goldman Sachs 38th Annual Global Healthcare Conference

Jun 6, 2017
3:30 PM ET
Jefferies 2017 Global Healthcare Conference

Apr 26, 2017
8:30 AM ET
The American Academy of Neurology (AAN) Annual Meeting 2017

Presentations
Date Title
Nov 15, 2017
= add file to Briefcase